Skip to main content
. 2022 Jan 20;20:24. doi: 10.1186/s12916-021-02212-0

Fig. 4.

Fig. 4

Gut barrier dysfunction in COVID-19 patients. a Number of human proteins detected in fecal samples from COVID-19 patients and controls. b Human-to-all DNA ratio detected in fecal samples from COVID-19 patients and controls. c The relative abundances of candidate human fecal proteins related to gastrointestinal damage